Software - Application
Compare Stocks
5 / 10Stock Comparison
SSNC vs NTRS vs TROW vs IVZ vs GS
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
Financial - Capital Markets
SSNC vs NTRS vs TROW vs IVZ vs GS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Asset Management | Asset Management | Asset Management | Financial - Capital Markets |
| Market Cap | $16.92B | $29.66B | $22.54B | $11.92B | $287.62B |
| Revenue (TTM) | $6.41B | $14.30B | $7.31B | $6.38B | $126.85B |
| Net Income (TTM) | $810M | $1.74B | $2.09B | $-243M | $16.67B |
| Gross Margin | 48.0% | 56.5% | 62.7% | 43.2% | 41.1% |
| Operating Margin | 23.1% | 16.3% | 29.9% | -10.9% | 14.5% |
| Forward P/E | 10.1x | 14.8x | 11.2x | 10.4x | 15.6x |
| Total Debt | $7.65B | $16.43B | $860M | $10.12B | $616.93B |
| Cash & Equiv. | $3.57B | $61.13B | $3.38B | $1.98B | $182.09B |
SSNC vs NTRS vs TROW vs IVZ vs GS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| SS&C Technologies H… (SSNC) | 100 | 121.0 | +21.0% |
| Northern Trust Corp… (NTRS) | 100 | 202.5 | +102.5% |
| T. Rowe Price Group… (TROW) | 100 | 85.7 | -14.3% |
| Invesco Ltd. (IVZ) | 100 | 336.6 | +236.6% |
| The Goldman Sachs G… (GS) | 100 | 471.2 | +371.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SSNC vs NTRS vs TROW vs IVZ vs GS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SSNC is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.79, current ratio 1.07x
- Lower P/E (10.1x vs 11.2x)
- Beta 0.79 vs IVZ's 1.67
Among these 5 stocks, NTRS doesn't own a clear edge in any measured category.
TROW carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 3 yrs, beta 1.18, yield 4.9%
- Beta 1.18, yield 4.9%, current ratio 73.08x
- NIM 3.4% vs GS's 0.5%
- 28.5% margin vs IVZ's -4.4%
IVZ ranks third and is worth considering specifically for momentum.
- +93.1% vs SSNC's -7.3%
GS is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 17.0%, EPS growth 77.3%
- 5.3% 10Y total return vs NTRS's 170.2%
- PEG 1.12 vs SSNC's 1.68
- 17.0% NII/revenue growth vs NTRS's -9.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 17.0% NII/revenue growth vs NTRS's -9.9% | |
| Value | Lower P/E (10.1x vs 11.2x) | |
| Quality / Margins | 28.5% margin vs IVZ's -4.4% | |
| Stability / Safety | Beta 0.79 vs IVZ's 1.67 | |
| Dividends | 4.9% yield, 3-year raise streak, vs GS's 1.5% | |
| Momentum (1Y) | +93.1% vs SSNC's -7.3% | |
| Efficiency (ROA) | 14.4% ROA vs IVZ's -0.9%, ROIC 13.3% vs -2.3% |
SSNC vs NTRS vs TROW vs IVZ vs GS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SSNC vs NTRS vs TROW vs IVZ vs GS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TROW leads in 2 of 6 categories
IVZ leads 1 • GS leads 1 • SSNC leads 0 • NTRS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TROW leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
GS is the larger business by revenue, generating $126.9B annually — 19.9x IVZ's $6.4B. TROW is the more profitable business, keeping 28.5% of every revenue dollar as net income compared to IVZ's -4.4%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $6.4B | $14.3B | $7.3B | $6.4B | $126.9B |
| EBITDAEarnings before interest/tax | $2.0B | $3.2B | $2.7B | $1.2B | $23.4B |
| Net IncomeAfter-tax profit | $810M | $1.7B | $2.1B | -$243M | $16.7B |
| Free Cash FlowCash after capex | $1.7B | $4.7B | $2.3B | $1.9B | $15.8B |
| Gross MarginGross profit ÷ Revenue | +48.0% | +56.5% | +62.7% | +43.2% | +41.1% |
| Operating MarginEBIT ÷ Revenue | +23.1% | +16.3% | +29.9% | -10.9% | +14.5% |
| Net MarginNet income ÷ Revenue | +12.6% | +12.1% | +28.5% | -4.4% | +11.3% |
| FCF MarginFCF ÷ Revenue | +26.7% | +38.2% | +20.2% | +22.6% | -12.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.8% | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +8.3% | +7.1% | +3.7% | +34.2% | +45.8% |
Valuation Metrics
IVZ leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 11.2x trailing earnings, TROW trades at a 51% valuation discount to GS's 22.8x P/E. Adjusting for growth (PEG ratio), GS offers better value at 1.63x vs SSNC's 3.69x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $16.9B | $29.7B | $22.5B | $11.9B | $287.6B |
| Enterprise ValueMkt cap + debt − cash | $21.0B | -$15.0B | $20.0B | $20.1B | $722.5B |
| Trailing P/EPrice ÷ TTM EPS | 22.25x | 18.31x | 11.20x | -16.77x | 22.84x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.14x | 14.80x | 11.22x | 10.44x | 15.64x |
| PEG RatioP/E ÷ EPS growth rate | 3.69x | 1.86x | — | — | 1.63x |
| EV / EBITDAEnterprise value multiple | 9.81x | -4.68x | 7.64x | 16.34x | 34.75x |
| Price / SalesMarket cap ÷ Revenue | 2.70x | 2.07x | 3.08x | 1.87x | 2.27x |
| Price / BookPrice ÷ Book value/share | 2.56x | 2.33x | 1.92x | 0.94x | 2.53x |
| Price / FCFMarket cap ÷ FCF | 10.17x | 5.43x | 15.24x | 8.27x | — |
Profitability & Efficiency
TROW leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
TROW delivers a 17.6% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-2 for IVZ. TROW carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 5.06x. On the Piotroski fundamental quality scale (0–9), NTRS scores 6/9 vs GS's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.6% | +13.4% | +17.6% | -1.7% | +12.6% |
| ROA (TTM)Return on assets | +4.1% | +1.0% | +14.4% | -0.9% | +0.9% |
| ROICReturn on invested capital | +8.9% | +6.0% | +13.3% | -2.3% | +1.9% |
| ROCEReturn on capital employed | +9.5% | +9.0% | +15.9% | -2.6% | +3.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 4 | 6 | 4 |
| Debt / EquityFinancial leverage | 1.10x | 1.27x | 0.07x | 0.78x | 5.06x |
| Net DebtTotal debt minus cash | $4.1B | -$44.7B | -$2.5B | $8.1B | $434.8B |
| Cash & Equiv.Liquid assets | $3.6B | $61.1B | $3.4B | $2.0B | $182.1B |
| Total DebtShort + long-term debt | $7.6B | $16.4B | $860M | $10.1B | $616.9B |
| Interest CoverageEBIT ÷ Interest expense | 4.80x | 0.38x | — | -6.19x | 0.31x |
Total Returns (Dividends Reinvested)
GS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GS five years ago would be worth $26,440 today (with dividends reinvested), compared to $6,915 for TROW. Over the past 12 months, IVZ leads with a +93.1% total return vs SSNC's -7.3%. The 3-year compound annual growth rate (CAGR) favors GS at 43.5% vs TROW's 3.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -18.0% | +15.5% | +0.2% | +0.4% | +1.8% |
| 1-Year ReturnPast 12 months | -7.3% | +66.6% | +18.9% | +93.1% | +70.6% |
| 3-Year ReturnCumulative with dividends | +30.9% | +131.7% | +11.5% | +79.8% | +195.2% |
| 5-Year ReturnCumulative with dividends | +1.7% | +46.7% | -30.9% | +8.2% | +164.4% |
| 10-Year ReturnCumulative with dividends | +164.9% | +170.2% | +93.6% | +22.1% | +534.3% |
| CAGR (3Y)Annualised 3-year return | +9.4% | +32.3% | +3.7% | +21.6% | +43.5% |
Risk & Volatility
Evenly matched — SSNC and GS each lead in 1 of 2 comparable metrics.
Risk & Volatility
SSNC is the less volatile stock with a 0.79 beta — it tends to amplify market swings less than IVZ's 1.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GS currently trades 94.0% from its 52-week high vs SSNC's 77.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.79x | 1.14x | 1.18x | 1.67x | 1.47x |
| 52-Week HighHighest price in past year | $91.07 | $173.19 | $118.22 | $29.61 | $984.70 |
| 52-Week LowLowest price in past year | $65.06 | $97.00 | $85.51 | $14.10 | $547.74 |
| % of 52W HighCurrent price vs 52-week peak | +77.0% | +92.4% | +87.6% | +90.6% | +94.0% |
| RSI (14)Momentum oscillator 0–100 | 48.3 | 59.4 | 78.2 | 69.4 | 59.5 |
| Avg Volume (50D)Average daily shares traded | 2.5M | 1.1M | 2.3M | 5.1M | 2.0M |
Analyst Outlook
Evenly matched — SSNC and TROW and GS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SSNC as "Buy", NTRS as "Hold", TROW as "Hold", IVZ as "Hold", GS as "Hold". Consensus price targets imply 34.4% upside for SSNC (target: $94) vs -3.9% for NTRS (target: $154). For income investors, TROW offers the higher dividend yield at 4.93% vs SSNC's 1.43%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $94.20 | $153.75 | $101.20 | $29.72 | $995.89 |
| # AnalystsCovering analysts | 24 | 35 | 38 | 28 | 55 |
| Dividend YieldAnnual dividend ÷ price | +1.4% | +2.0% | +4.9% | +3.1% | +1.5% |
| Dividend StreakConsecutive years of raises | 12 | 1 | 3 | 4 | 12 |
| Dividend / ShareAnnual DPS | $1.00 | $3.14 | $5.11 | $0.83 | $13.48 |
| Buyback YieldShare repurchases ÷ mkt cap | +6.1% | +4.3% | +2.8% | +15.6% | +3.5% |
TROW leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IVZ leads in 1 (Valuation Metrics). 2 tied.
SSNC vs NTRS vs TROW vs IVZ vs GS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SSNC or NTRS or TROW or IVZ or GS a better buy right now?
For growth investors, The Goldman Sachs Group, Inc.
(GS) is the stronger pick with 17. 0% revenue growth year-over-year, versus -9. 9% for Northern Trust Corporation (NTRS). T. Rowe Price Group, Inc. (TROW) offers the better valuation at 11. 2x trailing P/E (11. 2x forward), making it the more compelling value choice. Analysts rate SS&C Technologies Holdings, Inc. (SSNC) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SSNC or NTRS or TROW or IVZ or GS?
On trailing P/E, T.
Rowe Price Group, Inc. (TROW) is the cheapest at 11. 2x versus The Goldman Sachs Group, Inc. at 22. 8x. On forward P/E, SS&C Technologies Holdings, Inc. is actually cheaper at 10. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Goldman Sachs Group, Inc. wins at 1. 12x versus SS&C Technologies Holdings, Inc. 's 1. 68x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — SSNC or NTRS or TROW or IVZ or GS?
Over the past 5 years, The Goldman Sachs Group, Inc.
(GS) delivered a total return of +164. 4%, compared to -30. 9% for T. Rowe Price Group, Inc. (TROW). Over 10 years, the gap is even starker: GS returned +534. 3% versus IVZ's +22. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SSNC or NTRS or TROW or IVZ or GS?
By beta (market sensitivity over 5 years), SS&C Technologies Holdings, Inc.
(SSNC) is the lower-risk stock at 0. 79β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 111% more volatile than SSNC relative to the S&P 500. On balance sheet safety, T. Rowe Price Group, Inc. (TROW) carries a lower debt/equity ratio of 7% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SSNC or NTRS or TROW or IVZ or GS?
By revenue growth (latest reported year), The Goldman Sachs Group, Inc.
(GS) is pulling ahead at 17. 0% versus -9. 9% for Northern Trust Corporation (NTRS). On earnings-per-share growth, the picture is similar: The Goldman Sachs Group, Inc. grew EPS 77. 3% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SSNC or NTRS or TROW or IVZ or GS?
T.
Rowe Price Group, Inc. (TROW) is the more profitable company, earning 28. 5% net margin versus -4. 4% for Invesco Ltd. — meaning it keeps 28. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TROW leads at 29. 9% versus -10. 9% for IVZ. At the gross margin level — before operating expenses — TROW leads at 62. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SSNC or NTRS or TROW or IVZ or GS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, The Goldman Sachs Group, Inc. (GS) is the more undervalued stock at a PEG of 1. 12x versus SS&C Technologies Holdings, Inc. 's 1. 68x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, SS&C Technologies Holdings, Inc. (SSNC) trades at 10. 1x forward P/E versus 15. 6x for The Goldman Sachs Group, Inc. — 5. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SSNC: 34. 4% to $94. 20.
08Which pays a better dividend — SSNC or NTRS or TROW or IVZ or GS?
All stocks in this comparison pay dividends.
T. Rowe Price Group, Inc. (TROW) offers the highest yield at 4. 9%, versus 1. 4% for SS&C Technologies Holdings, Inc. (SSNC).
09Is SSNC or NTRS or TROW or IVZ or GS better for a retirement portfolio?
For long-horizon retirement investors, SS&C Technologies Holdings, Inc.
(SSNC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 79), 1. 4% yield, +164. 9% 10Y return). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SSNC: +164. 9%, IVZ: +22. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SSNC and NTRS and TROW and IVZ and GS?
These companies operate in different sectors (SSNC (Technology) and NTRS (Financial Services) and TROW (Financial Services) and IVZ (Financial Services) and GS (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SSNC is a mid-cap quality compounder stock; NTRS is a mid-cap quality compounder stock; TROW is a mid-cap deep-value stock; IVZ is a mid-cap income-oriented stock; GS is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.